secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025159
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics receives Nasdaq delisting notice for equity and filing non-compliance
--------------------------------------------------------------------------------

- Stockholders' equity fell below $2.5M minimum per Listing Rule 5550(b)(1) as of June 30, 2025.
- Company also cited for delayed Form 10-Q for quarter ended September 30, 2025 (Rule 5250(c)(1)).
- Will request hearing before Nasdaq Hearings Panel; automatic 15-day stay of suspension granted.
- Common stock and warrants will continue trading on Nasdaq during automatic stay and any extended stay.
- Company expects to file the overdue 10-Q imminently but no assurance Panel will grant relief.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225025159/0001493152-25-025159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225025159/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer